Safety of Catheter Ablation Therapy for Atrial Fibrillation in Cardiac Amyloidosis

BACKGROUND: Despite the high burden of atrial fibrillation in cardiac amyloidosis (CA), the safety of catheter ablation therapy in CA is not well established. We sought to examine short‐term safety outcomes following atrial fibrillation ablation in patients with CA compared with matched patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhassan, Hassan A., Kainat, Aleesha, Donohue, Joseph, Baumgartner, Scott J., Akunor, Harriet, Saba, Samir, Jain, Sandeep, Soman, Prem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382095/
https://www.ncbi.nlm.nih.gov/pubmed/37449569
http://dx.doi.org/10.1161/JAHA.122.029339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382095/
https://www.ncbi.nlm.nih.gov/pubmed/37449569
http://dx.doi.org/10.1161/JAHA.122.029339

Ejemplares similares